<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Assessment of Vaginal Bleeding - Interactive Algorithm</title>
    <style>
        :root {
            --assessment: #1976d2;
            --diagnosis: #7b1fa2;
            --treatment: #388e3c;
            --followup: #f57c00;
            --urgent: #d32f2f;
            --caution: #f57c00;
            --stable: #388e3c;
            --bg: #f5f7fa;
            --card: #ffffff;
            --text: #2c3e50;
            --border: #e1e8ed;
            --shadow: rgba(0, 0, 0, 0.1);
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        @import url('https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap');

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.6;
            overflow-x: hidden;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 2rem;
            display: grid;
            grid-template-columns: 1fr 250px;
            gap: 2rem;
        }

        .header {
            grid-column: 1 / -1;
            background: linear-gradient(135deg, var(--assessment), var(--diagnosis));
            color: white;
            padding: 2.5rem;
            border-radius: 12px;
            box-shadow: 0 4px 20px var(--shadow);
            margin-bottom: 1rem;
        }

        .header h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
        }

        .header p {
            font-size: 1.1rem;
            opacity: 0.9;
        }

        .main-content {
            display: flex;
            flex-direction: column;
            gap: 2rem;
        }

        .section {
            background: var(--card);
            border-radius: 12px;
            box-shadow: 0 4px 15px var(--shadow);
            overflow: hidden;
            transition: all 0.3s ease;
            opacity: 0;
            transform: translateY(20px);
        }

        .section.visible {
            opacity: 1;
            transform: translateY(0);
        }

        .section-header {
            padding: 1.5rem 2rem;
            color: white;
            display: flex;
            align-items: center;
            gap: 1rem;
            cursor: pointer;
            transition: all 0.3s ease;
            position: relative;
        }

        .section-header:hover {
            filter: brightness(1.1);
        }

        .section-header.assessment { background: var(--assessment); }
        .section-header.diagnosis { background: var(--diagnosis); }
        .section-header.treatment { background: var(--treatment); }
        .section-header.followup { background: var(--followup); }

        .section-icon {
            font-size: 2rem;
            width: 50px;
            height: 50px;
            display: flex;
            align-items: center;
            justify-content: center;
            background: rgba(255, 255, 255, 0.2);
            border-radius: 50%;
        }

        .section-title {
            flex: 1;
        }

        .section-title h2 {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 0.25rem;
        }

        .section-title p {
            font-size: 0.9rem;
            opacity: 0.9;
        }

        .expand-icon {
            font-size: 1.5rem;
            transition: transform 0.3s ease;
        }

        .section.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .section-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }

        .section.expanded .section-content {
            max-height: 3000px;
        }

        .subsection {
            padding: 1.5rem 2rem;
            border-bottom: 1px solid var(--border);
            transition: background 0.2s ease;
        }

        .subsection:hover {
            background: rgba(0, 0, 0, 0.02);
        }

        .subsection:last-child {
            border-bottom: none;
        }

        .subsection h3 {
            color: var(--text);
            margin-bottom: 0.75rem;
            font-size: 1.2rem;
            font-weight: 600;
        }

        .subsection h4 {
            color: var(--text);
            margin: 1rem 0 0.5rem;
            font-size: 1rem;
            font-weight: 600;
        }

        .subsection ul {
            margin-left: 1.5rem;
            margin-bottom: 1rem;
        }

        .subsection li {
            margin-bottom: 0.5rem;
        }

        .badge-container {
            display: flex;
            gap: 0.5rem;
            margin: 1rem 0;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 20px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            display: inline-flex;
            align-items: center;
            gap: 0.25rem;
        }

        .badge.urgent {
            background: rgba(211, 47, 47, 0.1);
            color: var(--urgent);
            border: 1px solid rgba(211, 47, 47, 0.3);
        }

        .badge.caution {
            background: rgba(245, 124, 0, 0.1);
            color: var(--caution);
            border: 1px solid rgba(245, 124, 0, 0.3);
        }

        .badge.stable {
            background: rgba(56, 142, 60, 0.1);
            color: var(--stable);
            border: 1px solid rgba(56, 142, 60, 0.3);
        }

        .sidebar {
            position: sticky;
            top: 2rem;
            height: fit-content;
        }

        .progress-nav {
            background: var(--card);
            border-radius: 12px;
            box-shadow: 0 4px 15px var(--shadow);
            padding: 1.5rem;
        }

        .progress-nav h3 {
            font-size: 1.1rem;
            font-weight: 600;
            margin-bottom: 1rem;
            color: var(--text);
        }

        .nav-item {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem;
            margin-bottom: 0.5rem;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            border-left: 3px solid transparent;
        }

        .nav-item:hover {
            background: var(--bg);
        }

        .nav-item.active {
            background: rgba(25, 118, 210, 0.1);
            border-left-color: var(--assessment);
        }

        .nav-item.active:nth-child(2) {
            background: rgba(123, 31, 162, 0.1);
            border-left-color: var(--diagnosis);
        }

        .nav-item.active:nth-child(3) {
            background: rgba(56, 142, 60, 0.1);
            border-left-color: var(--treatment);
        }

        .nav-item.active:nth-child(4) {
            background: rgba(245, 124, 0, 0.1);
            border-left-color: var(--followup);
        }

        .nav-icon {
            width: 24px;
            height: 24px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 50%;
            color: white;
            font-size: 0.8rem;
            font-weight: 600;
        }

        .nav-icon.assessment { background: var(--assessment); }
        .nav-icon.diagnosis { background: var(--diagnosis); }
        .nav-icon.treatment { background: var(--treatment); }
        .nav-icon.followup { background: var(--followup); }

        .nav-text {
            flex: 1;
            font-size: 0.9rem;
            font-weight: 500;
        }

        .nav-indicator {
            width: 8px;
            height: 8px;
            border-radius: 50%;
            background: var(--border);
            transition: all 0.3s ease;
        }

        .nav-item.completed .nav-indicator {
            background: var(--stable);
        }

        .nav-item.active .nav-indicator {
            background: currentColor;
            transform: scale(1.3);
        }

        .age-group {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
            border-left: 4px solid var(--assessment);
        }

        .condition-card {
            background: white;
            border-radius: 8px;
            padding: 1rem;
            margin: 0.75rem 0;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            border-left: 4px solid var(--caution);
        }

        .condition-card.urgent {
            border-left-color: var(--urgent);
        }

        .condition-card.stable {
            border-left-color: var(--stable);
        }

        .highlight-box {
            background: rgba(25, 118, 210, 0.05);
            border: 1px solid rgba(25, 118, 210, 0.2);
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .warning-box {
            background: rgba(211, 47, 47, 0.05);
            border: 1px solid rgba(211, 47, 47, 0.2);
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .emergency-banner {
            background: linear-gradient(135deg, var(--urgent), #b71c1c);
            color: white;
            padding: 1rem;
            border-radius: 8px;
            margin: 1rem 0;
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.75rem;
        }

        .emergency-banner::before {
            content: "üö®";
            font-size: 1.5rem;
        }

        .investigation-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1rem;
            margin: 1rem 0;
        }

        .investigation-item {
            background: white;
            border: 1px solid var(--border);
            border-radius: 8px;
            padding: 1rem;
        }

        .investigation-item strong {
            color: var(--text);
            display: block;
            margin-bottom: 0.5rem;
        }

        .management-step {
            background: linear-gradient(135deg, rgba(56, 142, 60, 0.1), rgba(56, 142, 60, 0.05));
            border-left: 4px solid var(--treatment);
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .footer {
            grid-column: 1 / -1;
            text-align: center;
            padding: 2rem;
            color: #7f8c8d;
            font-size: 0.9rem;
        }

        @media (max-width: 1024px) {
            .container {
                grid-template-columns: 1fr;
            }
            
            .sidebar {
                position: relative;
                top: 0;
            }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-in;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .pulse {
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0% { transform: scale(1); }
            50% { transform: scale(1.05); }
            100% { transform: scale(1); }
        }
    </style>
</head>
<body>
    <div class="container">
        <header class="header">
            <h1>Assessment of Vaginal Bleeding</h1>
            <p>Interactive Clinical Decision Support Tool | BMJ Best Practice Guidelines (Aug 2025)</p>
        </header>

        <main class="main-content">
            <!-- Assessment Section -->
            <section class="section" data-section="assessment">
                <div class="section-header assessment" onclick="toggleSection(this)">
                    <div class="section-icon">üìã</div>
                    <div class="section-title">
                        <h2>Assessment & Initial Evaluation</h2>
                        <p>Comprehensive history, examination & risk stratification</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="section-content">
                    <div class="subsection">
                        <h3>üéØ Key Principle</h3>
                        <div class="highlight-box">
                            <p><strong>First, determine the patient's age group and pregnancy status.</strong> This determines the differential diagnosis and urgency of evaluation.</p>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üìä Age-Based Classification</h3>
                        <div class="age-group">
                            <h4>üë∂ Premenarchal (Before Menarche)</h4>
                            <ul>
                                <li>Neonatal uterine bleeding (days 3-5 of life) - normal physiological</li>
                                <li>After neonatal period: ALWAYS abnormal</li>
                                <li>Consider trauma, foreign body, infection, sexual abuse, malignancy</li>
                            </ul>
                            <span class="badge urgent">Sexual abuse must be considered</span>
                        </div>

                        <div class="age-group">
                            <h4>üå∏ Reproductive Age (Non-Pregnant)</h4>
                            <ul>
                                <li>Postcoital bleeding: cervical ectropion, polyps, cervicitis, cancer</li>
                                <li>Intermenstrual bleeding: hormonal, structural, malignant causes</li>
                                <li>Heavy menstrual bleeding: evaluate for underlying pathology</li>
                            </ul>
                        </div>

                        <div class="age-group">
                            <h4>ü§∞ Reproductive Age (Pregnant)</h4>
                            <ul>
                                <li><strong>First trimester:</strong> Ectopic pregnancy, miscarriage</li>
                                <li><strong>Second/third trimester:</strong> Placental abruption, placenta praevia, preterm labor</li>
                            </ul>
                            <span class="badge urgent">Ectopic pregnancy is life-threatening</span>
                        </div>

                        <div class="age-group">
                            <h4>üëµ Postmenopausal</h4>
                            <ul>
                                <li>Any bleeding >12 months after last period is abnormal</li>
                                <li>>90% of endometrial cancers present with postmenopausal bleeding</li>
                                <li>9% of women with postmenopausal bleeding have endometrial cancer</li>
                            </ul>
                            <span class="badge urgent">Urgent cancer investigation required</span>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üìù History Taking</h3>
                        <div class="condition-card">
                            <h4>All Patients</h4>
                            <ul>
                                <li><strong>Characterize bleeding:</strong> Frequency, volume, duration, pattern</li>
                                <li><strong>Precipitating factors:</strong> Intercourse, trauma, medication</li>
                                <li><strong>Associated symptoms:</strong> Pain, discharge, dizziness, shoulder pain</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Pregnancy-Related Red Flags üö®</h4>
                            <ul>
                                <li>Unstable vital signs (hypotension, tachycardia)</li>
                                <li>Severe abdominal pain or acute abdomen</li>
                                <li>Shoulder tip pain (diaphragmatic irritation)</li>
                                <li>Cervical motion tenderness</li>
                                <li>Dizziness or syncope</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Reproductive Age Women</h4>
                            <ul>
                                <li>Last menstrual period date</li>
                                <li>Contraception use and adherence</li>
                                <li>Sexual activity and STI risk</li>
                                <li>Previous cervical screening results</li>
                                <li>HPV vaccination/infection history</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Postmenopausal Women</h4>
                            <ul>
                                <li>Exact date of last menstrual period</li>
                                <li>Hormone replacement therapy use</li>
                                <li>Risk factors: obesity, tamoxifen use, PCOS history</li>
                                <li>Family history of gynecological cancers</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Prepubertal Girls üö®</h4>
                            <ul>
                                <li>Signs of puberty development (breast, pubic hair)</li>
                                <li>History of trauma (straddle injuries common)</li>
                                <li>Possible foreign body insertion</li>
                                <li>Behavioral changes suggesting abuse</li>
                                <li>Always consider possibility of sexual abuse</li>
                            </ul>
                        </div>
                    </div>

                <div class="subsection">
                    <h3>üî¨ Physical Examination</h3>
                    <div class="emergency-banner">
                        DO NOT perform digital vaginal examination if placenta praevia is suspected until ultrasound excludes it
                    </div>
                    
                    <div class="investigation-grid">
                        <div class="investigation-item">
                            <strong>Vital Signs</strong>
                            <p>Hemodynamic stability assessment. Check BP, pulse, temperature in all patients with significant bleeding.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>General Inspection</strong>
                            <p>Vulva, perineum, anal area for lesions, fissures, or external sources of bleeding.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Speculum Examination</strong>
                            <p>Identify cervical/vaginal lesions: polyps, ectropion, cancer, cervicitis, foreign bodies.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Bimanual Examination</strong>
                            <p>Cervical motion tenderness, adnexal mass/tenderness, uterine size/mobility.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Abdominal Examination</strong>
                            <p>Uterine size (pregnancy), tenderness, guarding, signs of intra-abdominal bleeding.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Special Considerations</strong>
                            <p>Prepubertal girls rarely need internal exam; consider sedation/anesthesia. Follow abuse protocols if indicated.</p>
                        </div>
                    </div>
                </div>

                    <div class="subsection">
                        <h3>üß™ Initial Investigations</h3>
                        <div class="condition-card">
                            <h4>Pregnancy Status (All Women of Reproductive Age)</h4>
                            <ul>
                                <li><strong>Urinary hCG:</strong> Immediate bedside test</li>
                                <li><strong>Serum hCG:</strong> Quantitative if pregnancy confirmed or diagnostic uncertainty</li>
                                <li><strong>Serial hCG:</strong> 48-hour intervals to monitor trend (<50% drop suggests failing pregnancy, >50% rise suggests ongoing pregnancy)</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Hematological & Baseline Tests</h4>
                            <ul>
                                <li><strong>Full Blood Count:</strong> Assess anemia from blood loss</li>
                                <li><strong>Blood Group & Rh Status:</strong> Essential for pregnant women (determines anti-D need)</li>
                                <li><strong>Kleihauer-Betke Test:</strong> Quantifies feto-maternal hemorrhage</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Infection Screening (When Indicated)</h4>
                            <ul>
                                <li><strong>NAAT for Chlamydia & Gonorrhea:</strong> High sensitivity/specificity</li>
                                <li><strong>Wet mount microscopy:</strong> Trichomonas, bacterial vaginosis, candidiasis</li>
                                <li><strong>Vaginal pH testing:</strong> >4.5 suggests bacterial infection</li>
                                <li><strong>HIV, Hepatitis B/C, Syphilis:</strong> Offer with any STI diagnosis</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Endocrine Tests (Precocious Puberty)</h4>
                            <ul>
                                <li><strong>Serum LH, FSH, Estrogen:</strong> Differentiate gonadotropin-dependent vs independent</li>
                                <li><strong>Androgen panel:</strong> DHEA, DHEA-S</li>
                                <li><strong>Bone age assessment:</strong> Left hand/wrist radiograph</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üîç Imaging & Special Investigations</h3>
                        <div class="condition-card urgent">
                            <h4>Transvaginal/Transabdominal Ultrasound (First-Line)</h4>
                            <ul>
                                <li><strong>Pregnancy:</strong> Confirm location (intrauterine vs ectopic), viability, gestational age</li>
                                <li><strong>Postmenopausal bleeding:</strong> Endometrial thickness ‚â§4mm has >99% negative predictive value for cancer</li>
                                <li><strong>Structural lesions:</strong> Fibroids, polyps, ovarian masses, placenta location</li>
                                <li><strong>Placental abruption:</strong> 96% specific but only 24% sensitive</li>
                            </ul>
                        </div>

                        <div class="investigation-item">
                            <strong>Colposcopy</strong>
                            <p>For persistent postcoital bleeding or suspicious cervical lesions. Allows directed biopsy of abnormal areas.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>MRI</strong>
                            <p>Assess myometrial invasion in endometrial cancer, parametrial involvement in cervical cancer.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>CT Scan</strong>
                            <p>Staging for suspected advanced gynecological cancers (pelvis, abdomen, nodes, liver metastases).</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Endometrial Biopsy</strong>
                            <p>Indicated in postmenopausal bleeding with thickened endometrium, risk factors, or recurrent bleeding.</p>
                        </div>
                        <div class="investigation-item">
                            <strong>Cervical Biopsy</strong>
                            <p>Any suspicious cervical lesion visible on speculum or colposcopy examination.</p>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Diagnosis Section -->
            <section class="section" data-section="diagnosis">
                <div class="section-header diagnosis" onclick="toggleSection(this)">
                    <div class="section-icon">üî¨</div>
                    <div class="section-title">
                        <h2>Differential Diagnosis</h2>
                        <p>Age-specific differentials with key diagnostic features</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="section-content">
                    <div class="subsection">
                        <h3>üö® Emergency Conditions (Immediate Action Required)</h3>
                        <div class="condition-card urgent">
                            <h4>Ruptured Ectopic Pregnancy</h4>
                            <div class="badge-container">
                                <span class="badge urgent">LIFE-THREATENING</span>
                                <span class="badge urgent">Surgical Emergency</span>
                            </div>
                            <ul>
                                <li><strong>History:</strong> Amenorrhea, abdominal pain, vaginal bleeding, shoulder tip pain</li>
                                <li><strong>Exam:</strong> Hypotension, tachycardia, abdominal guarding, cervical motion tenderness</li>
                                <li><strong>Investigations:</strong> Positive hCG, no intrauterine pregnancy on US, free fluid in pouch of Douglas</li>
                                <li><strong>Action:</strong> Emergency resuscitation, blood transfusion, immediate surgery</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Placental Abruption</h4>
                            <div class="badge-container">
                                <span class="badge urgent">Feto-Maternal Emergency</span>
                                <span class="badge urgent">2nd/3rd Trimester</span>
                            </div>
                            <ul>
                                <li><strong>History:</strong> Abdominal pain, vaginal bleeding, uterine contractions, risk factors (HTN, smoking, cocaine)</li>
                                <li><strong>Exam:</strong> Tender, hard uterus; hypotension/tachycardia if severe</li>
                                <li><strong>Investigations:</strong> FBC (anemia, thrombocytopenia), coagulation profile (DIC), ultrasound (limited sensitivity)</li>
                                <li><strong>Action:</strong> Stabilization, monitoring, prepare for delivery</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Placenta Praevia (Major)</h4>
                            <div class="badge-container">
                                <span class="badge urgent">Painless Bleeding</span>
                                <span class="badge urgent">2nd/3rd Trimester</span>
                            </div>
                            <ul>
                                <li><strong>History:</strong> Painless vaginal bleeding, previous cesarean, multiple pregnancies</li>
                                <li><strong>Exam:</strong> Avoid digital examination until US confirms! Soft, non-tender uterus</li>
                                <li><strong>Investigations:</strong> Transabdominal US confirms placenta overlying cervical os</li>
                                <li><strong>Action:</strong> Expectant management, prepare for cesarean delivery</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>ü©∏ Common Diagnoses by Age Group</h3>
                        
                        <div class="age-group">
                            <h4>üë∂ Premenarchal Girls</h4>
                            
                            <div class="condition-card stable">
                                <h4>Neonatal Uterine Bleeding (Normal)</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Self-limiting</span>
                                    <span class="badge stable">Days 3-5 of life</span>
                                </div>
                                <p>Due to maternal progesterone withdrawal. Resolves spontaneously, no treatment needed.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Vulvovaginitis</h4>
                                <div class="badge-container">
                                    <span class="badge caution">Most Common Cause</span>
                                    <span class="badge stable">Usually benign</span>
                                </div>
                                <p>Irritation from poor hygiene, foreign bodies (toilet paper, toys), infection. Rarely causes significant bleeding.</p>
                            </div>

                            <div class="condition-card urgent">
                                <h4>Sexual Abuse</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Must Exclude</span>
                                    <span class="badge urgent">Reportable</span>
                                </div>
                                <p>Non-specific findings often normal. Look for behavioral changes, somatic complaints, anogenital injuries. Follow local protocols.</p>
                            </div>

                            <div class="condition-card urgent">
                                <h4>Rhabdomyosarcoma (Rare)</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Malignant</span>
                                    <span class="badge urgent">Peak <2 years</span>
                                </div>
                                <p>"Grape-like" cluster at vaginal opening. Requires urgent oncology referral. Passage of tissue fragments is concerning.</p>
                            </div>

                            <div class="condition-card urgent">
                                <h4>Genital Trauma</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Straddle Injuries Common</span>
                                </div>
                                <p>Falls onto bicycle crossbar, chair arm, playground equipment. Examine under anesthesia if significant injury or urethral involvement suspected.</p>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>üå∏ Reproductive Age (Non-Pregnant)</h4>
                            
                            <div class="condition-card stable">
                                <h4>Cervical Ectropion</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Common & Benign</span>
                                    <span class="badge stable">Hormonal</span>
                                </div>
                                <p>Endocervical glandular epithelium visible on ectocervix. Common with OCP use, pregnancy, adolescence. Usually asymptomatic, may cause postcoital bleeding.</p>
                            </div>

                            <div class="condition-card stable">
                                <h4>Cervical Polyp</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Benign Neoplasm</span>
                                    <span class="badge caution">Usually >40 years</span>
                                </div>
                                <p>Smooth, lobular, friable mass seen on speculum. May cause contact bleeding. Usually benign but should be removed and histologically confirmed.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Cervicitis</h4>
                                <div class="badge-container">
                                    <span class="badge caution">Infectious</span>
                                    <span class="badge caution">STI Risk</span>
                                </div>
                                <p>Mucopurulent discharge, friable cervix, contact bleeding. Caused by Chlamydia, Gonorrhea, Trichomonas, Mycoplasma. "Strawberry cervix" with Trichomonas.</p>
                            </div>

                            <div class="condition-card urgent">
                                <h4>Cervical Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Malignant</span>
                                    <span class="badge urgent">HPV-Related</span>
                                </div>
                                <p>Contact bleeding, malodorous discharge, dyspareunia, pelvic/back pain. Risk increases with age: 1/44,000 (age 20-24) to 1/2,400 (age 45-54). Colposcopy and biopsy required.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Endometrial Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge caution">Usually >50 years</span>
                                    <span class="badge urgent">Obesity = Risk</span>
                                </div>
                                <p>Intermenstrual bleeding, postmenopausal bleeding. Risk factors: obesity, nulliparity, PCOS, tamoxifen, unopposed estrogen. Transvaginal US and endometrial biopsy needed.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Ovarian Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge caution">Non-specific Symptoms</span>
                                    <span class="badge caution">Adnexal Mass</span>
                                </div>
                                <p>Bloating, nausea, dyspepsia, urinary urgency may predominate. Pelvic mass on examination. Transvaginal US shows complex mass. CA-125 may be elevated. CT for staging.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Vaginal Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Rare <1% of GYN Cancers</span>
                                    <span class="badge urgent">HPV-Related</span>
                                </div>
                                <p>Primary vaginal cancer rare; usually metastatic. Postcoital bleeding, visible lesion on speculum. Requires biopsy for diagnosis.</p>
                            </div>

                            <div class="condition-card stable">
                                <h4>Vaginitis</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Common</span>
                                    <span class="badge stable">Infection/Atrophic</span>
                                </div>
                                <p>Candida: thick white discharge, pruritus, normal pH. Bacterial vaginosis: fishy odor, pH >4.5, clue cells. Atrophic: thin, friable mucosa in hypoestrogen state.</p>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>ü§∞ Reproductive Age (Pregnant)</h4>
                            
                            <div class="condition-card urgent">
                                <h4>Miscarriage (Spontaneous Abortion)</h4>
                                <div class="badge-container">
                                    <span class="badge caution">25% of pregnancies</span>
                                    <span class="badge urgent">1st Trimester</span>
                                </div>
                                <p>Vaginal bleeding ¬± clots, pelvic pain. US shows no viable intrauterine pregnancy. Serial hCG may be needed. Management: expectant, medical (misoprostol), or surgical depending on type.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Subchorionic Hematoma</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Usually resolves</span>
                                </div>
                                <p>Bleeding from chorionic membrane detachment. Seen on ultrasound. Most resolve spontaneously; may increase miscarriage risk if large.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Cervical Insufficiency</h4>
                                <div class="badge-container">
                                    <span class="badge caution">2nd Trimester</span>
                                </div>
                                <p>Painless cervical dilation with bleeding. Risk of preterm delivery. May require cervical cerclage.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Vasa Praevia</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Fetal Vessels Over OS</span>
                                </div>
                                <p>Fetal vessels cross cervical os. Painless vaginal bleeding, often with membrane rupture. Catastrophic fetal hemorrhage risk. Emergency cesarean required.</p>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>üëµ Postmenopausal Women</h4>
                            
                            <div class="condition-card urgent">
                                <h4>Endometrial Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Most Common (9%)</span>
                                    <span class="badge urgent">>90% Present with PMB</span>
                                </div>
                                <p>Unprovoked bleeding >12 months after menopause. Risk factors: obesity, unopposed estrogen, tamoxifen, HNPCC. Endometrial thickness >4mm on US requires biopsy.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Atrophic Vaginitis</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Very Common</span>
                                    <span class="badge caution">Hormone Deficiency</span>
                                </div>
                                <p>Thin, friable mucosa due to hypoestrogenism. May bleed with intercourse, pessary use, or spontaneously. Treat with topical estrogen.</p>
                            </div>

                            <div class="condition-card stable">
                                <h4>Hormone Replacement Therapy Bleeding</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Common (First 4-6 months)</span>
                                </div>
                                <p>Irregular bleeding common initially. If persistent beyond 6 months or heavy, investigate for endometrial pathology.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Cervical/Vaginal Cancer</h4>
                                <div class="badge-container">
                                    <span class="badge urgent">Risk Increases with Age</span>
                                </div>
                                <p>Postcoital or unexplained bleeding. Speculum examination may show lesion. Requires biopsy and staging.</p>
                            </div>

                            <div class="condition-card cautious">
                                <h4>Endometrial Polyps</h4>
                                <div class="badge-container">
                                    <span class="badge stable">Benign</span>
                                </div>
                                <p>Focal endometrial thickening on US. May cause intermenstrual or postmenopausal bleeding. Hysteroscopy and removal recommended.</p>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Treatment Section -->
            <section class="section" data-section="treatment">
                <div class="section-header treatment" onclick="toggleSection(this)">
                    <div class="section-icon">üíä</div>
                    <div class="section-title">
                        <h2>Treatment & Management</h2>
                        <p>Evidence-based management pathways by condition</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="section-content">
                    <div class="subsection">
                        <h3>üö® Emergency Management</h3>
                        
                        <div class="emergency-banner">
                            Ruptured Ectopic Pregnancy: Stabilize and Transfer to Operating Theatre Immediately
                        </div>

                        <div class="management-step">
                            <h4>1. Hemodynamic Resuscitation</h4>
                            <ul>
                                <li><strong>IV Access:</strong> Two large-bore cannulas (14-16G)</li>
                                <li><strong>Fluid Resuscitation:</strong> Crystalloids, colloids as needed</li>
                                <li><strong>Blood Products:</strong> O-negative or type-specific blood if unstable</li>
                                <li><strong>Monitoring:</strong> Continuous BP, pulse, urine output, oxygen saturation</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>2. Surgical Management</h4>
                            <ul>
                                <li><strong>Stable patient:</strong> Laparoscopic salpingectomy preferred</li>
                                <li><strong>Unstable patient:</strong> Laparotomy may be required</li>
                                <li><strong>Conservative:</strong> Salpingostomy if future fertility desired and contralateral tube healthy</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>3. Post-Operative Care</h4>
                            <ul>
                                <li><strong>Rh-negative:</strong> Give anti-D immunoglobulin</li>
                                <li><strong>Follow-up:</strong> Serial hCG until negative</li>
                                <li><strong>Fertility:</strong> Counseling about future pregnancy risk (10-27% recurrence)</li>
                            </ul>
                        </div>

                        <div class="emergency-banner">
                            Placental Abruption: Stabilize Mother & Fetus, Prepare for Delivery
                        </div>

                        <div class="management-step">
                            <h4>1. Initial Stabilization</h4>
                            <ul>
                                <li><strong>Maternal stabilization:</strong> IV access, monitoring, oxygen</li>
                                <li><strong>Fetal monitoring:</strong> Continuous CTG</li>
                                <li><strong>Blood work:</strong> FBC, coagulation profile, crossmatch</li>
                                <li><strong>Anti-D:</strong> If Rh-negative</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>2. Management Strategy</h4>
                            <ul>
                                <li><strong>Mild abruption (Grade 1):</strong> Expectant if mother & fetus stable, <34 weeks</li>
                                <li><strong>Moderate-Severe (Grade 2-3):</strong> Deliver immediately (usually vaginal if possible)</li>
                                <li><strong>DIC:</strong> Replace blood products (FFP, cryoprecipitate, platelets)</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üë∂ Premenarchal Girls</h3>
                        
                        <div class="condition-card stable">
                            <h4>Neonatal Uterine Bleeding</h4>
                            <ul>
                                <li><strong>Management:</strong> Reassurance only, self-limiting</li>
                                <li><strong>Duration:</strong> Resolves within days without intervention</li>
                                <li><strong>Parent education:</strong> Explain physiological cause</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Vulvovaginitis</h4>
                            <ul>
                                <li><strong>Hygiene measures:</strong> Avoid harsh soaps, bubble baths, tight clothing</li>
                                <li><strong>Foreign body removal:</strong> Under anesthesia if needed</li>
                                <li><strong>Infection:</strong> Treat specific pathogen (bacterial, candidal)</li>
                                <li><strong>Prevention:</strong> Cotton underwear, front-to-back wiping</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Suspected Sexual Abuse</h4>
                            <ul>
                                <li><strong>Immediate:</strong> Follow local child protection protocols</li>
                                <li><strong>Reporting:</strong> Mandatory reporting to authorities</li>
                                <li><strong>Examination:</strong> Specialist pediatric gynecology, possible forensic exam</li>
                                <li><strong>Support:</strong> Child advocacy center involvement, counseling services</li>
                                <li><strong>Documentation:</strong> Photographic evidence, detailed notes</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üå∏ Reproductive Age (Non-Pregnant)</h3>
                        
                        <div class="condition-card stable">
                            <h4>Cervical Ectropion</h4>
                            <ul>
                                <li><strong>Asymptomatic:</strong> No treatment needed</li>
                                <li><strong>Bothersome bleeding:</strong> Cauterization (silver nitrate, diathermy)</li>
                                <li><strong>Observation:</strong> Often resolves after stopping OCPs or postpartum</li>
                                <li><strong>Cervical screening:</strong> Ensure up-to-date cytology</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Cervical Polyp</h4>
                            <ul>
                                <li><strong>Removal:</strong> Office polypectomy (twist, ligate, or excise)</li>
                                <li><strong>Histology:</strong> Always send for pathological examination</li>
                                <li><strong>Follow-up:</strong> Recheck at next smear test</li>
                                <li><strong>Recurrence:</strong> Possible, repeat removal if needed</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Cervicitis</h4>
                            <ul>
                                <li><strong>Testing:</strong> NAAT for Chlamydia, Gonorrhea, Trichomonas</li>
                                <li><strong>Antibiotics:</strong> Empirical treatment while awaiting results
                                    <ul>
                                        <li>Chlamydia: Azithromycin 1g single dose OR Doxycycline 100mg BD 7 days</li>
                                        <li>Gonorrhea: Ceftriaxone 500mg IM single dose</li>
                                        <li>Trichomonas: Metronidazole 2g single dose</li>
                                    </ul>
                                </li>
                                <li><strong>Partner treatment:</strong> Essential for STIs</li>
                                <li><strong>Test of cure:</strong> Repeat NAAT in 3 months</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Cervical Cancer</h4>
                            <ul>
                                <li><strong>Referral:</strong> Urgent gynecology oncology (2-week wait pathway)</li>
                                <li><strong>Staging:</strong> MRI pelvis, CT chest/abdomen, examination under anesthesia</li>
                                <li><strong>Early stage:</strong> Surgery (cone biopsy, trachelectomy, hysterectomy)</li>
                                <li><strong>Advanced stage:</strong> Chemoradiation (cisplatin-based)</li>
                                <li><strong>Follow-up:</strong> Regular surveillance for recurrence</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Endometrial Cancer</h4>
                            <ul>
                                <li><strong>Referral:</strong> Urgent gynecology oncology</li>
                                <li><strong>Staging:</strong> Total hysterectomy, bilateral salpingo-oophorectomy, lymphadenectomy</li>
                                <li><strong>Adjuvant therapy:</strong> Radiotherapy, chemotherapy based on stage/grade</li>
                                <li><strong>Hormonal:</strong> Progestins for fertility-sparing in selected cases</li>
                                <li><strong>Surveillance:</strong> Regular follow-up for 5+ years</li>
                            </ul>
                        </div>

                        <div class="condition-card stable">
                            <h4>Vaginitis</h4>
                            <ul>
                                <li><strong>Candida:</strong> Fluconazole 150mg single dose OR topical azole (clotrimazole, miconazole)</li>
                                <li><strong>Bacterial vaginosis:</strong> Metronidazole 500mg BD 7 days OR 2g single dose</li>
                                <li><strong>Trichomonas:</strong> Metronidazole 2g single dose (partner treatment essential)</li>
                                <li><strong>Atrophic:</strong> Topical estrogen cream, vaginal tablet, or ring</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>ü§∞ Pregnancy-Related Management</h3>
                        
                        <div class="condition-card cautious">
                            <h4>Threatened Miscarriage</h4>
                            <ul>
                                <li><strong>Expectant management:</strong> If viable pregnancy on US, mild bleeding</li>
                                <li><strong>Bed rest:</strong> Not proven beneficial but commonly advised</li>
                                <li><strong>Avoid intercourse:</strong> Until bleeding resolves</li>
                                <li><strong>Rh prophylaxis:</strong> Anti-D 50¬µg if Rh-negative and <12 weeks, 250¬µg if ‚â•12 weeks</li>
                                <li><strong>Follow-up:</strong> Repeat scan in 1-2 weeks or if bleeding worsens</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Inevitable/Incomplete Miscarriage</h4>
                            <ul>
                                <li><strong>Expectant:</strong> Allow spontaneous completion if stable, <13 weeks</li>
                                <li><strong>Medical:</strong> Misoprostol 800¬µg vaginal or sublingual (repeat after 3 hours if needed)</li>
                                <li><strong>Surgical:</strong> Manual vacuum aspiration or D&C if heavy bleeding, infection, or patient preference</li>
                                <li><strong>Anti-D:</strong> As above for Rh-negative women</li>
                                <li><strong>Follow-up:</strong> Confirm complete evacuation (US or hCG)</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Missed Miscarriage</h4>
                            <ul>
                                <li><strong>All options available:</strong> Expectant, medical, or surgical</li>
                                <li><strong>Medical:</strong> Mifepristone 200mg oral followed by misoprostol</li>
                                <li><strong>Surgical:</strong> D&C or vacuum aspiration, especially if >13 weeks</li>
                                <li><strong>Timing:</strong> Patient can choose based on preference and stability</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Ectopic Pregnancy (Unruptured)</h4>
                            <ul>
                                <li><strong>Expectant:</strong> If hCG <1000 IU/L and falling, small size, asymptomatic</li>
                                <li><strong>Medical:</strong> Methotrexate 50mg/m¬≤ IM single dose if criteria met
                                    <ul>
                                        <li>Hemodynamically stable</li>
                                        <li>No fetal cardiac activity</li>
                                        <li>Heterogeneous mass <3.5cm</li>
                                        <li>Initial hCG <5000 IU/L</li>
                                    </ul>
                                </li>
                                <li><strong>Monitoring:</strong> Serial hCG days 4, 7 until negative</li>
                                <li><strong>Surgery:</strong> If rupture risk, high hCG, or failed medical treatment</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Subchorionic Hematoma</h4>
                            <ul>
                                <li><strong>Expectant:</strong> Most resolve spontaneously</li>
                                <li><strong>Pelvic rest:</strong> Avoid intercourse, heavy lifting</li>
                                <li><strong>Monitoring:</strong> Weekly ultrasound if symptomatic</li>
                                <li><strong>Prognosis:</strong> Generally good unless very large or recurrent bleeding</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Placenta Praevia (Minor, Stable)</h4>
                            <ul>
                                <li><strong>Expectant:</strong> If no active bleeding, fetus <36 weeks</li>
                                <li><strong>Pelvic rest:</strong> No intercourse, speculum, or digital exams</li>
                                <li><strong>Corticosteroids:</strong> If <34 weeks and bleeding risk</li>
                                <li><strong>Delivery:</strong> Planned cesarean at 36-37 weeks for major praevia</li>
                                <li><strong>Emergency:</strong> Immediate cesarean if major bleeding</li>
                            </ul>
                        </div>

                        <div class="condition-card urgent">
                            <h4>Vasa Praevia</h4>
                            <ul>
                                <li><strong>Emergency cesarean:</strong> Immediate delivery if ruptured</li>
                                <li><strong>Antenatal diagnosis:</strong> Hospitalization at 32 weeks, steroids, planned cesarean at 34-35 weeks</li>
                                <li><strong>Fetal mortality:</strong> >60% if undiagnosed and ruptures</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üëµ Postmenopausal Women</h3>
                        
                        <div class="condition-card urgent">
                            <h4>Endometrial Cancer</h4>
                            <ul>
                                <li><strong>Referral:</strong> Urgent gynecology oncology (2-week pathway)</li>
                                <li><strong>Surgery:</strong> Total hysterectomy, BSO, lymphadenectomy (staging)</li>
                                <li><strong>Adjuvant:</strong> Radiotherapy ¬± chemotherapy based on stage/grade</li>
                                <li><strong>Surveillance:</strong> Every 3-6 months for 2 years, then annually</li>
                                <li><strong>Prognosis:</strong> 5-year survival 80% for stage I, 15% for stage IV</li>
                            </ul>
                        </div>

                        <div class="condition-card stable">
                            <h4>Atrophic Vaginitis</h4>
                            <ul>
                                <li><strong>First-line:</strong> Topical vaginal estrogen (cream, tablet, or ring)</li>
                                <li><strong>Systemic:</strong> Consider if vasomotor symptoms also present</li>
                                <li><strong>Non-hormonal:</strong> Vaginal moisturizers, lubricants</li>
                                <li><strong>Dosing:</strong> Daily for 2 weeks, then twice weekly maintenance</li>
                                <li><strong>Alternative:</strong> Ospemifene (SERM) if estrogen contraindicated</li>
                            </ul>
                        </div>

                        <div class="condition-card stable">
                            <h4>HRT-Related Bleeding</h4>
                            <ul>
                                <li><strong>First 4-6 months:</strong> Reassurance, may be irregular</li>
                                <li><strong>Persistent >6 months:</strong> Investigation required (US, biopsy)</li>
                                <li><strong>Dose adjustment:</strong> Consider changing progestogen type/dose</li>
                                <li><strong>Alternative:</strong> Switch to continuous combined regimen</li>
                            </ul>
                        </div>

                        <div class="condition-card cautious">
                            <h4>Endometrial Polyps</h4>
                            <ul>
                                <li><strong>Hysteroscopic removal:</strong> Gold standard treatment</li>
                                <li><strong>Histology:</strong> Always send for pathological examination</li>
                                <li><strong>Recurrence:</strong> Possible; consider levonorgestrel IUD for prevention</li>
                                <li><strong>Postmenopausal:</strong> Removal recommended even if asymptomatic</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>ü¶† Sexually Transmitted Infections</h3>
                        
                        <div class="management-step">
                            <h4>Chlamydia trachomatis</h4>
                            <ul>
                                <li><strong>First-line:</strong> Doxycycline 100mg PO twice daily for 7 days</li>
                                <li><strong>Alternative:</strong> Azithromycin 1g PO single dose</li>
                                <li><strong>Pregnancy:</strong> Azithromycin 1g PO single dose (doxycycline contraindicated)</li>
                                <li><strong>Partner treatment:</strong> Essential, test for other STIs</li>
                                <li><strong>Test of cure:</strong> NAAT at 3 months</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>Neisseria gonorrhoeae</h4>
                            <ul>
                                <li><strong>First-line:</strong> Ceftriaxone 500mg IM single dose (1g if >150kg)</li>
                                <li><strong>Chlamydia co-treatment:</strong> Add doxycycline 100mg BD 7 days if not excluded</li>
                                <li><strong>Partner treatment:</strong> Essential</li>
                                <li><strong>Test of cure:</strong> NAAT at 2 weeks</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>Trichomonas vaginalis</h4>
                            <ul>
                                <li><strong>Metronidazole:</strong> 2g PO single dose OR 500mg BD 7 days</li>
                                <li><strong>Partners:</strong> Treat all sexual partners</li>
                                <li><strong>Test of cure:</strong> NAOT at 3 months</li>
                            </ul>
                        </div>

                        <div class="management-step">
                            <h4>Bacterial Vaginosis</h4>
                            <ul>
                                <li><strong>Symptomatic:</strong> Metronidazole 500mg BD 7 days OR 2g single dose</li>
                                <li><strong>Topical:</strong> Metronidazole 0.75% gel daily 5 days OR clindamycin 2% cream nightly 7 days</li>
                                <li><strong>Asymptomatic:</strong> Treatment not usually needed unless procedures planned</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Follow-up Section -->
            <section class="section" data-section="followup">
                <div class="section-header followup" onclick="toggleSection(this)">
                    <div class="section-icon">üìÖ</div>
                    <div class="section-title">
                        <h2>Follow-up & Referral</h2>
                        <p>Monitoring, prevention & long-term care pathways</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="section-content">
                    <div class="subsection">
                        <h3>üè• Referral Guidelines</h3>
                        
                        <div class="condition-card urgent">
                            <h4>Immediate/Urgent Referral (Same Day/24-48 Hours)</h4>
                            <div class="badge-container">
                                <span class="badge urgent">Emergency Department</span>
                                <span class="badge urgent">Gynecology On-Call</span>
                            </div>
                            <ul>
                                <li>üö® Ruptured ectopic pregnancy</li>
                                <li>üö® Severe placental abruption with maternal/fetal compromise</li>
                                <li>üö® Major placenta praevia with active bleeding</li>
                                <li>üö® Vasa praevia with ruptured membranes/bleeding</li>
                                <li>üö® Suspected cervical or endometrial cancer</li>
                                <li>üö® Suspected child sexual abuse</li>
                                <li>üö® Severe genital trauma</li>
                            </ul>
                        </div>

                        <div class="condition-card caution">
                            <h4>Urgent Referral (Within 2 Weeks)</h4>
                            <div class="badge-container">
                                <span class="badge caution">2-Week Wait Pathway</span>
                            </div>
                            <ul>
                                <li>Postmenopausal bleeding (any)</li>
                                <li>Persistent intermenstrual bleeding >3 months</li>
                                <li>Heavy postcoital bleeding >3 episodes</li>
                                <li>Suspicious cervical lesion on examination</li>
                                <li>Thickened endometrium >4mm in postmenopausal women</li>
                                <li>Atypical glandular cells on cervical cytology</li>
                                <li>Sus ovarian mass on US with concerning features</li>
                            </ul>
                        </div>

                        <div class="condition-card stable">
                            <h4>Routine Referral</h4>
                            <div class="badge-container">
                                <span class="badge stable">Outpatient Clinic</span>
                            </div>
                            <ul>
                                <li>Cervical polyps for removal</li>
                                <li>Recurrent cervicitis/vaginitis</li>
                                <li>Atrophic vaginitis not responding to first-line Rx</li>
                                <li>HRT counseling for bleeding management</li>
                                <li>Endometrial polyp removal (hysteroscopy)</li>
                            </ul>
                        </div>

                        <div class="condition-card stable">
                            <h4>Specialist Referrals</h4>
                            <ul>
                                <li><strong>Gynecologic Oncology:</strong> Confirmed or suspected cancers</li>
                                <li><strong>Reproductive Endocrinology:</strong> Complex hormonal issues, PCOS, precocious puberty</li>
                                <li><strong>Urogynecology:</strong> Associated urinary tract trauma or fistula</li>
                                <li><strong>Child Protection:</strong> Suspected abuse (always involve social services)</li>
                                <li><strong>Psychology/Counseling:</strong> Support after miscarriage, abuse, cancer diagnosis</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üìä Follow-up Schedules</h3>
                        
                        <div class="age-group">
                            <h4>After Miscarriage</h4>
                            <div class="condition-card">
                                <h4>Physical Follow-up</h4>
                                <ul>
                                    <li><strong>1 week:</strong> Review bleeding, pain, infection signs</li>
                                    <li><strong>2-3 weeks:</strong> Confirm complete evacuation (US or hCG <5 IU/L)</li>
                                    <li><strong>6 weeks:</strong> Cervical screening if due, assess menstrual return</li>
                                </ul>
                            </div>
                            <div class="condition-card">
                                <h4>Emotional Support</h4>
                                <ul>
                                    <li><strong>Early:</strong> Acknowledge grief, provide counseling resources</li>
                                    <li><strong>6 weeks:</strong> Screen for depression/anxiety</li>
                                    <li><strong>Next pregnancy:</strong> Preconception counseling, early US</li>
                                </ul>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>After Ectopic Pregnancy</h4>
                            <div class="condition-card">
                                <h4>Monitoring</h4>
                                <ul>
                                    <li><strong>Serial hCG:</strong> Days 4, 7 post-treatment until negative</li>
                                    <li><strong>Contraception:</strong> Advise 3 months after methotrexate (folate supplementation)</li>
                                    <li><strong>Fertility:</strong> Discuss 10-27% recurrence risk, early US in next pregnancy</li>
                                    <li><strong>Emotional:</strong> Support for pregnancy loss, future fertility concerns</li>
                                </ul>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>After Cervical Cancer Treatment</h4>
                            <div class="condition-card">
                                <h4>Surveillance</h4>
                                <ul>
                                    <li><strong>Years 1-2:</strong> Every 3-6 months (history, examination, smear if cervix preserved)</li>
                                    <li><strong>Years 3-5:</strong> Every 6 months</li>
                                    <li><strong>>5 years:</strong> Annually</li>
                                    <li><strong>Imaging:</strong> Annual CXR, CT/MRI if symptoms</li>
                                    <li><strong>Late effects:</strong> Lymphedema, vaginal stenosis, bowel/bladder issues</li>
                                </ul>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>After Endometrial Cancer Treatment</h4>
                            <div class="condition-card">
                                <h4>Surveillance</h4>
                                <ul>
                                    <li><strong>Every 3-6 months:</strong> For 2 years</li>
                                    <li><strong>Every 6 months:</strong> For 3 more years</li>
                                    <li><strong>Annually:</strong> After 5 years</li>
                                    <li><strong>Examinations:</strong> History, physical exam, vault smear if indicated</li>
                                    <li><strong>Imaging:</strong> CT/MRI for symptoms or exam findings</li>
                                    <li><strong>Recurrence risk:</strong> Highest in first 2-3 years</li>
                                </ul>
                            </div>
                        </div>

                        <div class="age-group">
                            <h4>Postmenopausal Bleeding Follow-up</h4>
                            <div class="condition-card">
                                <h4>Normal Investigations</h4>
                                <ul>
                                    <li><strong>Reassure:</strong> If endometrial thickness ‚â§4mm and no risk factors</li>
                                    <li><strong>Recurrent bleeding:</strong> Re-investigate (repeat US, hysteroscopy)</li>
                                    <li><strong>HRT:</strong> Review at 3, 6 months then annually</li>
                                    <li><strong>Cervical screening:</strong> Ensure up to date</li>
                                </ul>
                            </div>
                            <div class="condition-card">
                                <h4>Endometrial Hyperplasia (Benign)</h4>
                                <ul>
                                    <li><strong>Follow-up biopsy:</strong> Every 6-12 months</li>
                                    <li><strong>Progestin therapy:</strong> LNG-IUD or oral progestins</li>
                                    <li><strong>Risk assessment:</strong> Progression to cancer risk increases with atypia</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üõ°Ô∏è Prevention & Health Promotion</h3>
                        
                        <div class="condition-card">
                            <h4>Cervical Cancer Prevention</h4>
                            <ul>
                                <li><strong>HPV Vaccination:</strong> Offer to eligible age groups (9-45 years)</li>
                                <li><strong>Cervical Screening:</strong> 25-64 years (3-yearly 25-49, 5-yearly 50-64)</li>
                                <li><strong>Smoking Cessation:</strong> Reduce cervical cancer risk</li>
                                <li><strong>Safe Sex:</strong> Condoms reduce HPV transmission</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Endometrial Cancer Prevention</h4>
                            <ul>
                                <li><strong>Weight Management:</strong> Obesity ‚Üë estrogen exposure</li>
                                <li><strong>Diabetes Control:</strong> Insulin resistance is risk factor</li>
                                <li><strong>PCOS Management:</strong> Cyclical progestins to oppose estrogen</li>
                                <li><strong>Tamoxifen:</strong> Counsel about risks, consider surveillance</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>STI Prevention</h4>
                            <ul>
                                <li><strong>Barrier Protection:</strong> Condoms reduce transmission</li>
                                <li><strong>Partner Notification:</strong> Essential for treatment success</li>
                                <li><strong>Regular Screening:</strong> High-risk individuals</li>
                                <li><strong>Vaccination:</strong> Hepatitis B (if not immune)</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Ectopic Pregnancy Prevention</h4>
                            <ul>
                                <li><strong>STI Screening:</strong> Early treatment of chlamydia/gonorrhea</li>
                                <li><strong>Smoking Cessation:</strong> Reduces risk</li>
                                <li><strong>Early US:</strong> Confirm intrauterine pregnancy in next pregnancy</li>
                                <li><strong>LNG-IUD:</strong> Reduces but doesn't eliminate risk</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Menstrual Health Education</h4>
                            <ul>
                                <li><strong>Normal vs abnormal:</strong> Teach women to recognize concerning bleeding</li>
                                <li><strong>Record keeping:</strong> Menstrual apps/calendars</li>
                                <li><strong>When to seek care:</strong> Heavy bleeding, intermenstrual bleeding, postcoital bleeding</li>
                                <li><strong>Iron supplementation:</strong> If heavy menstrual bleeding</li>
                            </ul>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üì± Patient Resources & Support</h3>
                        
                        <div class="investigation-grid">
                            <div class="investigation-item">
                                <strong>Leaflets & Information</strong>
                                <ul>
                                    <li>Cervical screening information</li>
                                    <li>Heavy menstrual bleeding management</li>
                                    <li>Menopause and HRT facts</li>
                                    <li>STI prevention and treatment</li>
                                </ul>
                            </div>
                            <div class="investigation-item">
                                <strong>Support Groups</strong>
                                <ul>
                                    <li>Cancer support organizations</li>
                                    <li>Miscarriage association</li>
                                    <li>Domestic violence helplines</li>
                                    <li>Menopause support groups</li>
                                </ul>
                            </div>
                            <div class="investigation-item">
                                <strong>Online Resources</strong>
                                <ul>
                                    <li>BMJ Best Practice (professional)</li>
                                    <li>Patient.info (consumer)</li>
                                    <li>NICE guidelines (evidence-based)</li>
                                    <li>RCOG patient information</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="subsection">
                        <h3>üîç Quality Improvement</h3>
                        
                        <div class="condition-card">
                            <h4>Audit Indicators</h4>
                            <ul>
                                <li>Time from postmenopausal bleeding presentation to investigation</li>
                                <li>Proportion of pregnant women with bleeding who have documented Rh status</li>
                                <li>Anti-D administration rate in Rh-negative pregnant women</li>
                                <li>Follow-up rate after abnormal cervical screening</li>
                                <li>STI testing rates in women with cervicitis</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Key Performance Targets</h4>
                            <ul>
                                <li>Postmenopausal bleeding: Investigation within 2 weeks</li>
                                <li>2WW referrals: Seen within 2 weeks</li>
                                <li>Suspected cancer: Diagnosis within 28 days (UK target)</li>
                                <li>STI results: Communicated within 2 weeks</li>
                                <li>Miscarriage follow-up: Contact within 2 weeks</li>
                            </ul>
                        </div>

                        <div class="condition-card">
                            <h4>Reducing Variation</h4>
                            <ul>
                                <li>Standardized referral pathways by age group</li>
                                <li>Protocolized management of bleeding in pregnancy</li>
                                <li>Integrated care pathways for suspected cancer</li>
                                <li>Electronic decision support tools</li>
                                <li>Regular multidisciplinary team meetings</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

        <div class="footer">
            <p>¬© 2025 Clinical Decision Support Tool | Based on BMJ Best Practice Guidelines (Aug 2025)</p>
            <p>Always consult local protocols and specialist advice. This tool supports but does not replace clinical judgment.</p>
        </div>
        </main>

        <aside class="sidebar">
            <nav class="progress-nav">
                <h3>Algorithm Progress</h3>
                <div class="nav-item active" onclick="scrollToSection('assessment')">
                    <div class="nav-icon assessment">1</div>
                    <div class="nav-text">Assessment</div>
                    <div class="nav-indicator"></div>
                </div>
                <div class="nav-item" onclick="scrollToSection('diagnosis')">
                    <div class="nav-icon diagnosis">2</div>
                    <div class="nav-text">Diagnosis</div>
                    <div class="nav-indicator"></div>
                </div>
                <div class="nav-item" onclick="scrollToSection('treatment')">
                    <div class="nav-icon treatment">3</div>
                    <div class="nav-text">Treatment</div>
                    <div class="nav-indicator"></div>
                </div>
                <div class="nav-item" onclick="scrollToSection('followup')">
                    <div class="nav-icon followup">4</div>
                    <div class="nav-text">Follow-up</div>
                    <div class="nav-indicator"></div>
                </div>
            </nav>
        </aside>
    </div>

    <script>
        // Section toggle functionality
        function toggleSection(header) {
            const section = header.parentElement;
            section.classList.toggle('expanded');
            
            // Update progress indicator
            updateProgress();
        }

        // Scroll to section functionality
        function scrollToSection(sectionName) {
            const section = document.querySelector(`[data-section="${sectionName}"]`);
            if (section) {
                section.scrollIntoView({ behavior: 'smooth', block: 'start' });
                
                // Expand the section
                section.classList.add('expanded');
                
                // Update active nav item
                document.querySelectorAll('.nav-item').forEach(item => item.classList.remove('active'));
                event.target.closest('.nav-item').classList.add('active');
            }
        }

        // Update progress based on scroll position
        function updateProgress() {
            const sections = document.querySelectorAll('.section');
            const navItems = document.querySelectorAll('.nav-item');
            
            let currentSection = null;
            
            sections.forEach((section, index) => {
                const rect = section.getBoundingClientRect();
                if (rect.top <= 200 && rect.bottom >= 200) {
                    currentSection = index;
                }
            });
            
            if (currentSection !== null) {
                navItems.forEach((item, index) => {
                    item.classList.remove('active');
                    if (index === currentSection) {
                        item.classList.add('active');
                    }
                    // Mark as completed if section has been passed
                    if (index < currentSection) {
                        item.classList.add('completed');
                    }
                });
            }
        }

        // Intersection Observer for fade-in effect
        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.classList.add('visible', 'fade-in');
                }
            });
        }, { threshold: 0.1 });

        // Observe all sections
        document.querySelectorAll('.section').forEach(section => {
            observer.observe(section);
        });

        // Expand first section by default
        document.addEventListener('DOMContentLoaded', () => {
            const firstSection = document.querySelector('.section');
            if (firstSection) {
                firstSection.classList.add('expanded');
            }
            
            // Initialize progress
            updateProgress();
        });

        // Scroll event listener
        let scrollTimeout;
        window.addEventListener('scroll', () => {
            clearTimeout(scrollTimeout);
            scrollTimeout = setTimeout(updateProgress, 50);
        });

        // Add pulse animation to urgent badges
        document.querySelectorAll('.badge.urgent').forEach(badge => {
            badge.classList.add('pulse');
        });

        // Smooth scrolling for all internal links
        document.querySelectorAll('a[href^="#"]').forEach(link => {
            link.addEventListener('click', function(e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({ behavior: 'smooth' });
                }
            });
        });

        // Print functionality
        function printAlgorithm() {
            window.print();
        }

        // Add print button (optional)
        const printButton = document.createElement('button');
        printButton.innerHTML = 'üñ®Ô∏è Print Algorithm';
        printButton.style.cssText = `
            position: fixed;
            bottom: 20px;
            right: 20px;
            padding: 10px 15px;
            background: var(--assessment);
            color: white;
            border: none;
            border-radius: 5px;
            cursor: pointer;
            box-shadow: 0 2px 10px var(--shadow);
            z-index: 1000;
            transition: all 0.3s ease;
        `;
        printButton.onclick = printAlgorithm;
        document.body.appendChild(printButton);
    </script>
</body>
</html>